Efficacy and safety of the biosimilar ABP 215 compared with Bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (MAPLE): a randomized, double-blind, phase III study - Thatcher, Nicholas; Thomas, Michael (Clinical cancer research, 2019)
Gesehen am 30.01.2020